Guaranty Agreements in the Biotechnology Industry
46 Contracts & Agreements
- Acorda Therapeutics (1 contract)
- Adhera Therapeutics, Inc. (1)
- AgeX Therapeutics, Inc. (2)
- Akebia Therapeutics, Inc. (1)
- ALBIREO PHARMA, INC. (1)
- Alzamend Neuro, Inc. (1)
- AquaBounty Technologies, Inc. (2)
- ARCA biopharma, Inc. (1)
- CALADRIUS BIOSCIENCES, INC. (1)
- CTD HOLDINGS INC (2)
- CTI BIOPHARMA CORP (1)
- Fibrocell Science, Inc. (1)
- Fortress Biotech, Inc. (1)
- FS Development Corp. II (1)
- GENEREX BIOTECHNOLOGY CORP (1)
- Gilead Sciences (4)
- iBio, Inc. (1)
- Innovation Pharmaceuticals Inc. (3)
- INTERCEPT PHARMACEUTICALS, INC. (1)
- MADRIGAL PHARMACEUTICALS, INC. (1)
- MANHATTAN SCIENTIFICS INC (1)
- MARIZYME INC (1)
- MIRAGEN THERAPEUTICS, INC. (1)
- NOVAVAX INC (1)
- NTN BUZZTIME INC (1)
- OncBioMune Pharmaceuticals, Inc (2)
- ORAGENICS INC (1)
- Protagenic Therapeutics, Inc. (2)
- PROTEOSTASIS THERAPEUTICS, INC. (1)
- Regeneron Pharmaceuticals (3)
- Shuttle Pharmaceuticals Holdings, Inc. (1)
- Sun BioPharma, Inc. (1)
- Tonix Pharmaceuticals Holding Corp. (1)
- WINDTREE THERAPEUTICS INC (1)
- Continuing Guaranty Agreement, dated October 22, 2024, made by Cancer Prevention Pharmaceuticals, Inc. and Panbela Research, Inc., in favor of Nant Capital, LLC (Sun BioPharma, Inc., Filed With SEC on October 28, 2024)
- Form of Guaranty (Alzamend Neuro, Inc., Filed With SEC on April 30, 2024)
- Guaranty Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc. and Juvenescence Limited (AgeX Therapeutics, Inc., Filed With SEC on November 14, 2023)
- Guaranty Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc. and Juvenescence Limited (AgeX Therapeutics, Inc., Filed With SEC on November 14, 2023)
- Limited Guaranty, dated July 16, 2023 (FS Development Corp. II, Filed With SEC on July 17, 2023)
- Third Amended and Restated Guaranty, dated as of March 27, 2023, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC,... (Regeneron Pharmaceuticals, Filed With SEC on March 29, 2023)
- Form of Subsidiary Guaranty (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on January 12, 2023)
- Second Amended and Restated Guaranty, dated as of March 2, 2022, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC,... (Regeneron Pharmaceuticals, Filed With SEC on March 8, 2022)
- Form of Guaranty, dated as of May 19, 2021, of Marizyme Sciences, Inc., Somaceutica, Inc., and Somahlution, Inc (MARIZYME INC, Filed With SEC on February 14, 2022)
- Guaranty Agreement, dated November 1, 2021, by iBio, Inc. for the benefit of Woodforest National Bank (iBio, Inc., Filed With SEC on November 4, 2021)
- Unconditional Secured Guaranty and Pledge Agreement, dated December 22, 2020 by and between the Company (formerly known as Proteostasis Therapeutics, Inc.) and Hercules Capital,... (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on December 30, 2020)
- Guaranty by Aram Fuchs in favor of NTN Buzztime, Inc (NTN BUZZTIME INC, Filed With SEC on September 18, 2020)
- Unconditional and Continuing Guaranty Agreement by and between AquaBounty Farms, Inc. and First Farmers Bank and Trust, dated as of July 31, 2020 (AquaBounty Technologies, Inc., Filed With SEC on August 6, 2020)
- Unconditional and Continuing Secured Guaranty Agreement by and between AquaBounty Technologies, Inc. and First Farmers Bank and Trust, dated as of July 31, 2020 (AquaBounty Technologies, Inc., Filed With SEC on August 6, 2020)
- Form of Guaranty (Protagenic Therapeutics, Inc., Filed With SEC on November 21, 2019)
- Unconditional Guaranty, dates as August 7, 2019, by and between Akebia Therapeutics, Inc. and Silicon Valley Bank (Akebia Therapeutics, Inc., Filed With SEC on November 12, 2019)
- Amended and Restated Guaranty, dated as of May 2, 2019, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC, as... (Regeneron Pharmaceuticals, Filed With SEC on May 3, 2019)
- Guaranty, dated as of November 12, 2018, by and between Fortress Biotech, Inc. and InvaGen Pharmaceuticals Inc (Fortress Biotech, Inc., Filed With SEC on November 16, 2018)
- Subsidiary Guaranty Agreement, dated September 24, 2018 (OncBioMune Pharmaceuticals, Inc, Filed With SEC on November 14, 2018)
- Guaranty and Replenishment Agreement (WINDTREE THERAPEUTICS INC, Filed With SEC on June 19, 2018)
- FORMOF SUBSIDIARY GUARANTY (OncBioMune Pharmaceuticals, Inc, Filed With SEC on November 21, 2016)
- GUARANTY AND SECURITY AGREEMENT (ALBIREO PHARMA, INC., Filed With SEC on November 4, 2016)
- GUARANTY (ORAGENICS INC, Filed With SEC on June 27, 2016)
- GUARANTY AND SECURITY AGREEMENT Dated as of November 3, 2011 among SIGNAL GENETICS, LLC, MYELOMA HEALTH LLC, RESPIRA HEALTH LLC and CC HEALTH LLC, as the Borrowers, and Each Other... (MIRAGEN THERAPEUTICS, INC., Filed With SEC on March 19, 2014)
- GUARANTY OF PAYMENT (CALADRIUS BIOSCIENCES, INC., Filed With SEC on December 13, 2013)
- GUARANTY AND SECURITY AGREEMENT Dated as of April 3, 2013 (MANHATTAN SCIENTIFICS INC, Filed With SEC on April 9, 2013)
- GUARANTY (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on September 4, 2012)
- SUBSIDIARY GUARANTY (Fibrocell Science, Inc., Filed With SEC on June 1, 2012)
- SUBSIDIARY GUARANTY (Tonix Pharmaceuticals Holding Corp., Filed With SEC on October 14, 2011)
- GUARANTY (Protagenic Therapeutics, Inc., Filed With SEC on June 1, 2011)
- GUARANTY (Continuing Debt - Unlimited) (CTD HOLDINGS INC, Filed With SEC on March 28, 2011)
- GUARANTY (Continuing Debt Unlimited) (CTD HOLDINGS INC, Filed With SEC on March 28, 2011)
- AMENDED AND RESTATED GUARANTY (Innovation Pharmaceuticals Inc., Filed With SEC on February 22, 2011)
- AMENDED AND RESTATED GUARANTY (Innovation Pharmaceuticals Inc., Filed With SEC on February 22, 2011)
- GUARANTY (MADRIGAL PHARMACEUTICALS, INC., Filed With SEC on October 5, 2010)
- GUARANTY AGREEMENT (Adhera Therapeutics, Inc., Filed With SEC on April 6, 2010)
- GUARANTY (Innovation Pharmaceuticals Inc., Filed With SEC on May 15, 2008)
- GUARANTY (GENEREX BIOTECHNOLOGY CORP, Filed With SEC on April 2, 2008)
- PARENT GUARANTY AGREEMENT (Gilead Sciences, Filed With SEC on December 19, 2007)
- FIRST AMENDMENT TO REVENUE INTERESTS ASSIGNMENT AGREEMENT AND TO GUARANTY (Acorda Therapeutics, Filed With SEC on November 29, 2006)
